Navigation Links
Ibuprofen and Vitamins C and E Could Halt Alzheimer's

A new study has suggested that patients who are at a high risk for developing Alzheimer's disease would benefit from taking a combination of vitamins E and C// plus ibuprofen. This therapy appears to be of maximum benefit in people who have a mutated gene for apolipoprotein, APOE-4, which is a high-risk condition predisposing them to Alzheimer's disease.

Researchers at the Johns Hopkins University in Baltimore monitored nearly 5000 elderly residents of Cache County in Utah for about 8 years and analyzed their intake of vitamins C and E, and ibuprofen. They found that there were 127 people who regularly took all three drugs. These people exhibited less decline in their mental performance, lead researcher Dr. Majid Fotuhi said at the American Academy of Neurology's annual meeting. "With this approach, we've advanced a two-point attack on the cascade of events that leads to Alzheimer's disease pathology," he said. "On the one hand, we reduce inflammation (with vitamins E and C), and on the other hand, we reduce the amount of amyloid in the brain (with ibuprofen), the substrate that causes inflammation." APOE-4 carriers seemed to have the biggest benefit from the combination of all three drugs. And these patients, all in their 60s or 70s did not show any decline in their mental faculties in the 8-year follow-up study. "So if patients seem to be at high risk, such as having several family members with Alzheimer's disease or with early memory loss, they are likely to benefit the most from the triple-combination therapy," the researchers said. Fotuhi, however cautions against using too much ibuprofen since it is known to cause stomach ulcers. A dosage of 100 milligrams per day appears to be enough, he said.
'"/>




Page: 1

Related medicine news :

1. Ibuprofen weakens aspirins effect
2. Ibuprofen to lower risk of Parkinson’s diseas
3. Safest painkiller Ibuprofen found to cause severe GI bleeding
4. Use Of Ibuprofen Safe For Short Periods
5. Long-term Ibuprofen Therapy After Brain Injury Deteriorate Cognitive Abilities
6. Children Find Effective Pain Relief With Ibuprofen
7. Ibuprofen Risky for Heart Patients?
8. Vitamins-The answer to Heart Disease?
9. Vitamins reduce pre-eclampsia
10. Vitamins enhances recuperation of organ transplant patients
11. Vitamins suppress artery injury after transplant
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... With ... intervention to walk, the demand for a sustainable product to aid in the rehabilitation ... and aid in the recovery of individuals with hemiplegia due to stroke. , Ekso ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
(Date:5/26/2016)... ... 2016 , ... Cabot Corporation, Pfizer, and 3M are responsible ... documents and SEC filings. A jury has returned a verdict of $32.8 ... Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million in ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... LifeScienceIndustryResearch.com adds "Ulcerative Colitis ... with comprehensive information on the therapeutic development for ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Ulcerative Colitis ...
(Date:5/27/2016)... -- Hutchison China MediTech (Chi-Med) (HCM) ... highly lucrative global oncology and immunology markets. HCM ... or best-in-class tyrosine kinase inhibitor (TKI) drugs, some ... HCM,s profitable Chinese healthcare business continues to benefit ... of the mid-to-late-stage pipeline during 2016-17 (including US ...
(Date:5/26/2016)... India , May 26, 2016 ... drugs market growth is the emergence of new treatments. ... astaxanthin therapies for osteoarthritis treatment. The therapy is expected ... Moreover, Arthritis Research UK is conducting studies to develop ... arcOGEN study, where the genes involved in osteoarthritis are ...
Breaking Medicine Technology: